ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Up 17.1% in November

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) was the target of a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 8,900 shares, an increase of 17.1% from the October 31st total of 7,600 shares. Based on an average daily volume of 12,800 shares, the days-to-cover ratio is presently 0.7 days.

ProShares Ultra Nasdaq Biotechnology Stock Up 0.3 %

Shares of NASDAQ BIB traded up $0.17 during midday trading on Monday, hitting $59.70. 5,586 shares of the company’s stock were exchanged, compared to its average volume of 23,125. The business’s fifty day moving average price is $61.60 and its two-hundred day moving average price is $62.08. ProShares Ultra Nasdaq Biotechnology has a 12-month low of $46.07 and a 12-month high of $69.56.

ProShares Ultra Nasdaq Biotechnology Increases Dividend

The firm also recently declared a dividend, which was paid on Wednesday, October 2nd. Shareholders of record on Wednesday, September 25th were paid a $0.1528 dividend. The ex-dividend date of this dividend was Wednesday, September 25th. This is an increase from ProShares Ultra Nasdaq Biotechnology’s previous dividend of $0.04.

Institutional Trading of ProShares Ultra Nasdaq Biotechnology

A hedge fund recently raised its stake in ProShares Ultra Nasdaq Biotechnology stock. Jane Street Group LLC boosted its position in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) by 8.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,803 shares of the exchange traded fund’s stock after purchasing an additional 374 shares during the quarter. Jane Street Group LLC owned approximately 0.35% of ProShares Ultra Nasdaq Biotechnology worth $306,000 at the end of the most recent quarter.

About ProShares Ultra Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.